BI 3031185 Clinical Trials
2 recruitingDrug
Phase 12
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study to Test How BI 3031185 is Tolerated by People With Borderline Personality Disorder or Attention-deficit/Hyperactivity Disorder
Attention Deficit Hyperactivity DisorderBorderline Personality Disorder
Boehringer Ingelheim96 enrolled12 locationsNCT07001475
Recruiting
Phase 1
A Study to Test How Well Different Doses of BI 3031185 Are Tolerated by Healthy Men
Healthy
Boehringer Ingelheim60 enrolled1 locationNCT06916702